Heart rate in coronary syndromes and heart failure.

In the past 2 decades, there have been growing evidences that resting heart rate might be a marker of risk or even a risk factor for cardiovascular morbidity and mortality. This article reviews current evidences concerning the relation between heart rate and patients' outcome in different clinical settings such as acute coronary syndromes, left ventricular systolic dysfunction, and heart failure. The relationship between resting heart rate and the development of coronary artery disease, as well as all-cause and cardiovascular mortality, has been found to be strong, graded, and independent from other risk factors. Several lines of research indicate that heart rate plays an important role in the pathophysiology of atherosclerosis and in the clinical manifestations of coronary artery disease and that it is an independent prognostic factor in all coronary syndromes. The prognostic value of elevated heart rate in patients with heart failure has been tested in several clinical trials evaluating pharmacologic heart rate-lowering agents (eg, beta-blockers). It is difficult to determine which percentage of the clinical benefit obtained with beta-blockers is related to induced bradycardia because cardiac slowing is only one of the effects of these drugs. In the BEAUTIFUL trial, a subgroup analysis conducted in patients with resting HR more than 70 beats per minute showed that treatment with ivabradine was able to improve outcome. According to the results presented in this review, we can conclude that heart rate is a predictor of death in both stable coronary artery disease and acute coronary syndromes. Elevated heart rate is also able to negatively predict clinical outcomes in patients with heart failure. However, it is still unclear if heart rate reduction per se can improve prognosis.

[1]  Masafumi Kitakaze,et al.  ER stress in cardiovascular disease. , 2010, Journal of molecular and cellular cardiology.

[2]  F. Lallemand,et al.  Long-Term Heart Rate Reduction Induced by the Selective If Current Inhibitor Ivabradine Improves Left Ventricular Function and Intrinsic Myocardial Structure in Congestive Heart Failure , 2004, Circulation.

[3]  M. Hetzel,et al.  Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency BIsoprolol Study (CIBIS). , 1997, Circulation.

[4]  U. Heidland,et al.  Left Ventricular Muscle Mass and Elevated Heart Rate Are Associated With Coronary Plaque Disruption , 2001, Circulation.

[5]  S. Gottlieb,et al.  What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF). , 2005, Journal of the American College of Cardiology.

[6]  P. Withagen,et al.  Combination of calcium channel blockers and beta-adrenoceptor blockers for patients with exercise-induced angina pectoris: a double-blind parallel-group comparison of different classes of calcium channel blockers. Netherlands Working Group on Cardiovascular Research (WCN). , 1999 .

[7]  Jean-Claude Tardif,et al.  Resting heart rate in cardiovascular disease. , 2007, Journal of the American College of Cardiology.

[8]  B D Kuban,et al.  Relationship between the geometry and quantitative morphology of the left anterior descending coronary artery. , 1996, Atherosclerosis.

[9]  B. Gersh,et al.  Bradycardia is associated with development of coronary collateral vessels in humans , 2000, Coronary artery disease.

[10]  J. Cleland,et al.  The effect of altering heart rate on ventricular function in patients with heart failure treated with beta-blockers. , 2006, American heart journal.

[11]  A. Quyyumi,et al.  Role of increases in heart rate in determining the occurrence and frequency of myocardial ischemia during daily life in patients with stable coronary artery disease. , 1992, Journal of the American College of Cardiology.

[12]  Jean-Claude Tardif,et al.  Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. , 2005, European heart journal.

[13]  A. Maggioni,et al.  Relevance of heart rate as a prognostic factor in patients with acute myocardial infarction: insights from the GISSI-2 study. , 1998, European heart journal.

[14]  H A Lindberg,et al.  Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. , 1980, American journal of epidemiology.

[15]  A. Mallet,et al.  Heart Rate and Cardiac Rhythm Relationships With Bisoprolol Benefit in Chronic Heart Failure in CIBIS II Trial , 2001, Circulation.

[16]  N. Geller,et al.  Comparison of subgroups assigned to medical regimens used to suppress cardiac ischemia (the Asymptomatic Cardiac Ischemia Pilot [ACIP] Study). , 1996, The American journal of cardiology.

[17]  C. Zarins,et al.  Retarding effect of lowered heart rate on coronary atherosclerosis. , 1984, Science.

[18]  E Casiglia,et al.  High heart rate: a risk factor for cardiovascular death in elderly men. , 1999, Archives of internal medicine.

[19]  P. Macfarlane,et al.  Heart rate, ischaemic heart disease, and sudden cardiac death in middle-aged British men. , 1993, British heart journal.

[20]  G Cooper,et al.  Bradycardia and the role of beta-blockade in the amelioration of left ventricular dysfunction. , 2000, Circulation.

[21]  D R Nul,et al.  Heart rate is a marker of amiodarone mortality reduction in severe heart failure. The GESICA-GEMA Investigators. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina-Grupo de Estudios Multicéntricos en Argentina. , 1997, Journal of the American College of Cardiology.

[22]  H. Levine.  Rest heart rate and life expectancy. , 1997, Journal of the American College of Cardiology.

[23]  J. Kjekshus,et al.  Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials. , 1986, The American journal of cardiology.

[24]  B. Carabello,et al.  Effects of chronic beta-adrenergic blockade on the left ventricular and cardiocyte abnormalities of chronic canine mitral regurgitation. , 1994, The Journal of clinical investigation.

[25]  Yan Li,et al.  Pulse pressure amplification, adiposity and metabolic syndrome in subjects under chronic antihypertensive therapy: the role of heart rate. , 2008, Atherosclerosis.

[26]  R. Califf,et al.  Predictors of stroke within 30 days in patients with non-ST-segment elevation acute coronary syndromes. , 2006, European heart journal.

[27]  W. Aronow,et al.  Association of average heart rate on 24-hour ambulatory electrocardiograms with incidence of new coronary events at 48-month follow-up in 1,311 patients (mean age 81 years) with heart disease and sinus rhythm. , 1996, The American journal of cardiology.

[28]  Y. Chatzizisis,et al.  Spatial and phasic oscillation of non-Newtonian wall shear stress in human left coronary artery bifurcation: an insight to atherogenesis , 2006, Coronary artery disease.

[29]  P. Poole‐Wilson,et al.  Mode of death in heart failure: findings from the ATLAS trial , 2003, Heart.

[30]  Yiannis S Chatzizisis,et al.  Coronary hemodynamics and atherosclerotic wall stiffness: a vicious cycle. , 2007, Medical hypotheses.

[31]  C. Cannon,et al.  Does initial and delayed heart rate predict mortality in patients with acute coronary syndromes? , 2004, Clinical cardiology.

[32]  P. Palatini,et al.  Heart rate as a predictor of development of sustained hypertension in subjects screened for stage 1 hypertension: the HARVEST Study , 2006, Journal of hypertension.

[33]  D. Mikhailidis,et al.  Elevated heart rate and atherosclerosis: an overview of the pathogenetic mechanisms. , 2008, International journal of cardiology.

[34]  H. Valantine,et al.  Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy. , 1989, Circulation.

[35]  R. Ferrari,et al.  Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial , 2008, The Lancet.

[36]  J. Schwartz,et al.  Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. , 1996, Circulation.

[37]  Pedro de Araújo Gonçalves,et al.  TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE-ACS. , 2005 .

[38]  V. Dzau.  Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. , 2001, Hypertension.

[39]  C. Bulpitt,et al.  Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension. , 2002, Archives of internal medicine.

[40]  Hui Zhu,et al.  Relationship Between the Dynamic Geometry and Wall Thickness of a Human Coronary Artery , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[41]  R S Paffenbarger,et al.  Heart rate and cardiovascular mortality: the Framingham Study. , 1987, American heart journal.

[42]  P. Libby,et al.  Pathophysiology of Coronary Artery Disease , 2005, Circulation.